From Research to Real-World Impact: The Journey of Commercializing a Breakthrough Device for Diabetic Neuropathy
Dr. Greta Preatoni, CEO & Co-founder of MYNERVA AG, will share how her PhD research in Neuroengineering at ETH Zurich evolved into a medtech startup tackling diabetic neuropathy. She will discuss transitioning from an engineering mindset to focusing on understanding the problem, refining the product vision, and building a multidisciplinary team. The talk will explore practical lessons on navigating regulatory requirements, testing assumptions, and securing early traction. Dr. Preatoni will also share personal reflections on the challenges, unexpected detours, and key decisions that shaped MYNERVA’s journey, offering insights for researchers and entrepreneurs working to bring innovation to market.
